These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 18097584)
1. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells. Kanayama S; Yamada Y; Kawaguchi R; Tsuji Y; Haruta S; Kobayashi H Oncol Rep; 2008 Jan; 19(1):117-22. PubMed ID: 18097584 [TBL] [Abstract][Full Text] [Related]
2. Signaling pathway involved in cyclooxygenase-2 up-regulation by hepatocyte growth factor in endometrial cancer cells. Yoshizawa Y; Yamada Y; Kanayama S; Shigetomi H; Kawaguchi R; Yoshida S; Nagai A; Furukawa N; Oi H; Kobayashi H Oncol Rep; 2011 Oct; 26(4):957-64. PubMed ID: 21687953 [TBL] [Abstract][Full Text] [Related]
3. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991 [TBL] [Abstract][Full Text] [Related]
4. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Gao J; Tian J; Lv Y; Shi F; Kong F; Shi H; Zhao L Cancer Sci; 2009 Mar; 100(3):389-95. PubMed ID: 19154413 [TBL] [Abstract][Full Text] [Related]
5. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness. Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Matsushita A; Götze T; Korc M Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973 [TBL] [Abstract][Full Text] [Related]
8. Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor. Chen JH; Wu CW; Kao HL; Chang HM; Li AF; Liu TY; Chi CW Cancer Lett; 2006 Aug; 239(2):263-70. PubMed ID: 16243430 [TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor. Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549. Liu G; Meng X; Jin Y; Bai J; Zhao Y; Cui X; Chen F; Fu S Cell Biol Int; 2008 Jun; 32(6):663-70. PubMed ID: 18343694 [TBL] [Abstract][Full Text] [Related]
12. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway]. Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076 [TBL] [Abstract][Full Text] [Related]
13. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Yu X; Liu L; Cai B; He Y; Wan X Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor prevents advanced glycation end products-induced injury and oxidative stress through a PI3K/Akt-dependent pathway in human endothelial cells. Zhou YJ; Yang HW; Wang XG; Zhang H Life Sci; 2009 Nov; 85(19-20):670-7. PubMed ID: 19778541 [TBL] [Abstract][Full Text] [Related]
16. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621 [TBL] [Abstract][Full Text] [Related]
17. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126. Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831 [TBL] [Abstract][Full Text] [Related]
18. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells. Ushio K; Hashimoto T; Kitamura N; Tanaka T Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783 [TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor induces proliferation of lens epithelial cells through activation of ERK1/2 and JNK/SAPK. Choi J; Park SY; Joo CK Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2696-704. PubMed ID: 15277494 [TBL] [Abstract][Full Text] [Related]
20. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]